Issues related to pharmaceutical drug pricing
2025 · 3rd Quarter (July 1 - Sep 30)
TEVA PHARMACEUTICALS USA, INC.
Filed by TALLEY STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Sep 8, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- TALLEY STRATEGIES LLC
- Filing UUID
- b83f409b-3e87-4419-89ec-670d9b8c4388
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmaceutical drug pricing
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.